Natco Pharma’s promoting accomplice gets USFDA gesture for anti cancer drug Kumar Jeetendra | June 14, 2021 New Delhi, Jun 14 (PTI) Natco Pharma on Monday said its marketing partner Breckenridge Pharmaceutical Inc has received approval from the US health regulator for anti-cancer drug Carfilzomib Vials. “Breckenridge Pharmaceutical Inc. (BPI), has received approval for its abbreviated new drug application (ANDA) for Carfilzomib Vials ANDA (generic for Kyprolis), from the US Food and …
Zydus Cadila gets USFDA conditional gesture for epilepsy treatment drug Kumar Jeetendra | June 14, 2021 New Delhi: Zydus Cadila on Monday said it has received tentative approval from the US health regulator to market epilepsy treatment drug Brivaracetam tablets. Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, Cadila Healthcare said in a …
Pfizer, AstraZeneca vaccines secure against Delta variant: Lancet study Kumar Jeetendra | June 15, 2021 The Delta variant of coronavirus, first identified in India, doubles the risk of hospitalisation compared with the Alpha variant first found in the UK, but Pfizer and AstraZeneca vaccines provide good protection against the strain, says a study published in The Lancet journal. Researchers at Public Health Scotland and the University of Edinburgh, UK, found …
Cherry Picking 2D Barcoded Sample Tubes Kumar Jeetendra | June 15, 2021 Ziath has posted a new video that shows how its Mohawk semi-automated tube selector is a productive and versatile tool for cherry picking tubes from multiple racks. In the new video – product manager Avash Anderson demonstrates how the Mohawk provides secure and accurate picking of individual 2D-barcoded tubes from 96-place SBS format racks – …
Weight-based dosing procedure may influence immunotherapy results, shows study Kumar Jeetendra | June 15, 2021 Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center. The findings, published in the Journal for ImmunoTherapy of Cancer, run counter to current practice trends, which favor fixed dosing, in which …
Thermo Fisher Scientific Expands SARS-CoV-2 Testing Portfolio in India with Point-of-Care Testing Platform Kumar Jeetendra | June 16, 2021 Mumbai, India, June 15, 2021–Thermo Fisher Scientific today announced a introduction of the new and innovative SARS-CoV-2 Test that delivers gold-standard reverse transcription polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format. The Accula SARS-CoV-2 Test has received Emergency Use Authorization (EUA) from the United States (U.S.) Food and Drug Administration (FDA) for …
Plug and Play Reactor Modules for Flow Chemistry Kumar Jeetendra | June 16, 2021 Uniqsis makes flow chemistry accessible to everyone, while at the same time catering for multi-step and automated reactions sequences, through the availability of an expanding suite of affordable ‘plug and play’ reactor modules. Compatible with all Uniqsis coil reactors and with an operating temperature range of ambient to +300°C, the HotCoil™ reactor heating module represents …
We didn’t back multiplying of vaccine dosing gap: Indian researchers Kumar Jeetendra | June 16, 2021 The Indian government doubled the gap between the two doses of the AstraZeneca COVID-19 vaccine without the agreement of the scientific group that it said recommended the increase, three members of the advisory body told Reuters. The ministry of health announced the decision to change the gap from 6-8 weeks to 12-16 weeks on May …
Sygnature Discovery expands into early CMC development Kumar Jeetendra | June 16, 2021 NOTTINGHAM, UK – 16 June, 2021 –– Leading Drug Discovery Contract Research Organisation Sygnature Discovery has announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. Located at its headquarters in Nottingham, UK, the new service line will expand on the company’s offerings to customers by bridging into formal preclinical drug development and paving …
Celemics Partner with Strand Life Science and their StrandOmics Analysis Platform Kumar Jeetendra | June 16, 2021 June 16, 2021, Seoul Korea – Celemics(www.celemics.com) co-founder and CEO Dr. Hyoki Kim announced a partnership with Strand Life Sciences, a leading precision medicine informatics company, to develop a bioinformatics solution capable of providing users with an accelerated means of producing high-quality, in-class clinical genomics reports and enabling a complete sample-to-answer solution, including assay-specific variant …
Which COVID vaccine is ideal? Here’s the reason that is truly difficult to reply Kumar Jeetendra | June 17, 2021 With the rollout of COVID-19 vaccines accelerating, people are increasingly asking which vaccine is best? Even if we tried to answer this question, defining which vaccine is “best” is not simple. Does that mean the vaccine better at protecting you from serious disease? The one that protects you from whichever variant is circulating near you? …
Perlara partners with Vivan Therapeutics to tackle rare genetic diseases Kumar Jeetendra | June 17, 2021 Berkeley, California, London, United Kingdom – June 17, 2021 – – Perlara PBC, a rare disease public benefit company today announced a rare genetic diseases collaboration with Vivan Therapeutics to identify novel therapeutics for rare genetic diseases. Under this agreement, Perlara will refer highly motivated patients, families and foundations seeking to embark on a discovery …
